A3793 — Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements.

A3793 — Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements. · Informed CitizenryThis bill amends existing law regarding drug manufacturing and wholesale non-prescription drug business registrations in New Jersey. It clarifies that approval from the U.S. Food and Drug Administr…Open in Informed Citizenry